Eculizumab
ECU-NMO-301
Phase 3 small_molecule terminated
Quick answer
Eculizumab for Neuromyelitis Optica is a Phase 3 program (small_molecule) at Alexion Europe SAS with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Alexion Europe SAS
- Indication
- Neuromyelitis Optica
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated